Publications by authors named "Erik Engel"

Claim this Profile
R
Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study.
Thomas Fietz, Mark-Oliver Zahn, Andreas Köhler, Erik Engel, Melanie Frank

Breast Cancer Res Treat· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study.
Norbert Marschner, Dirk Arnold, Erik Engel, Ulrich Hutzschenreuter, Jacqueline Rauh

Clin Epidemiol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer.
Friederike Braig, Manuela März, Aneta Schieferdecker, Alexander Schulte, Mareike Voigt, Erik Engel

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.
Kathrin Dellas, Thomas Höhler, Thomas Reese, Florian Würschmidt, Erik Engel

Radiat Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.
Gregor Dresemann, Michael Weller, Mark A Rosenthal, Ulrich Wedding, Wolfgang Wagner, Erik Engel

J Neurooncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis